# Committed to Health  _Beyond Today_

Improving life of patients with cardio-renal-metabolic disease for more than 140 years.

[Explore our original research product journey](https://pro.boehringer-ingelheim.com/in/quality-legacy-experience "Explore our original research product journey")

### Innovation in care

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

[Explore our products](https://pro.boehringer-ingelheim.com/in/products "Explore our products")

## Holistic Cardio-Renal-Metabolic care

### CVD Burden in India

Ischaemic heart disease and stroke vary across India, requiring **urgent health action.6**

[Learn more about HF](https://pro.boehringer-ingelheim.com/in/products/jardiance/heart-failure "Learn more about HF")

### CRM risk in India

**3 out of 5** newly diagnosed T2DM cases at very high CVD risk.2

[Learn more about T2DM](https://pro.boehringer-ingelheim.com/in/products/jardiance/jardiance-t2d/jardiance-overview "Learn more about T2DM")

### Burden of CKD in India

Kidney disease significantly contributes to **global morbidity and mortality.3**

[Learn more about CKD](https://pro.boehringer-ingelheim.com/in/products/jardiance/ckd "Learn more about CKD")

### Integrated management across interconnected risks

##### Why it matters:

- The burden of cardiovascular disease and CKD remains high in T2DM patients
- Delayed recognition of interconnected risks can lead to increased complications and mortality
- Early, integrated intervention across CV, renal, and metabolic domains is essential
- A holistic strategy enables better risk reduction and long-term patient outcomes

## Original research product

### Bioequivalence and therapeutic equivalence are not similar8,9

## Latest insights & updates

##### Can you conquer the Glyxambi Octet A1c League?

Navigate diabetes management challenges, score points with every correct decision, and progress through the league as you work towards championship status.

### JARDIANCE®: A 4-time Prix-Galien award winner recognised for scientific innovation and impact on human health18

(Prix-Galien is regarded as Noble prize in pharmaceutical research and development)

[Explore the Prix Galien journey](https://pro.boehringer-ingelheim.com/in/products/jardiance/jardiance-t2d/prix-galien-award "Explore the Prix Galien journey")

### References

01. Anjana RM, Unnikrishnan R, Mugilan P, et al. Causes and predictors of mortality in Asian Indians with and without diabetes-10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES - 150). _PLoS One_. 2018;13(7):e0197376.

02. Unnikrishnan AG, Sahay RK, Phadke U, et al. Cardiovascular risk in newly diagnosed type 2 diabetes patients in India. _PLoS One_. 2022;17(3):e0263619.

03. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. _Lancet_. 2020;395(10225):709-733.

08. Roy V, Rana P. Prescribing generics: All in a name. _Indian J Med Res_. 2018;147(5):442-444.

09. Chow SC. Bioavailability and bioequivalence in drug development. _Wiley Interdiscip Rev Comput Stat_. 2014;6(4):304-312.